J. Scott Wolchko
2021
In 2021, J. Scott Wolchko earned a total compensation of $11.7M as President, Chief Executive Officer and Director at Fate Therapeutics, a 109% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $366,000 |
|---|---|
| Option Awards | $1,200,000 |
| Salary | $610,000 |
| Stock Awards | $9,552,617 |
| Total | $11,728,617 |
Wolchko received $9.6M in stock awards, accounting for 81% of the total pay in 2021.
Wolchko also received $366K in non-equity incentive plan, $1.2M in option awards and $610K in salary.
Rankings
In 2021, J. Scott Wolchko's compensation ranked 804th out of 12,415 executives tracked by ExecPay. In other words, Wolchko earned more than 93.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 804 out of 12,415 | 94th |
Division Manufacturing | 264 out of 5,505 | 95th |
Major group Chemicals And Allied Products | 87 out of 2,375 | 96th |
Industry group Drugs | 74 out of 2,096 | 97th |
Industry Biological Products, Except Diagnostic Substances | 24 out of 449 | 95th |
Source: SEC filing on April 25, 2022.
Wolchko's colleagues
We found five more compensation records of executives who worked with J. Scott Wolchko at Fate Therapeutics in 2021.
2021
Mark Plavsic
Fate Therapeutics
Chief Technology Officer
2021
Bahram Valamehr
Fate Therapeutics
Chief Research and Development Officer
2021
Cindy Tahl
Fate Therapeutics
General Counsel
2021
Yu-Waye Chu
Fate Therapeutics
Chief Medical Officer
2021
Edward Dulac
Fate Therapeutics